ATE210656T1 - Heterocyclische ether-derivate zur verstärkung der cognitiven funktionen - Google Patents
Heterocyclische ether-derivate zur verstärkung der cognitiven funktionenInfo
- Publication number
- ATE210656T1 ATE210656T1 AT93923826T AT93923826T ATE210656T1 AT E210656 T1 ATE210656 T1 AT E210656T1 AT 93923826 T AT93923826 T AT 93923826T AT 93923826 T AT93923826 T AT 93923826T AT E210656 T1 ATE210656 T1 AT E210656T1
- Authority
- AT
- Austria
- Prior art keywords
- heterocyclic ether
- ether derivatives
- cognitive functions
- enhance cognitive
- cholinergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95900592A | 1992-10-09 | 1992-10-09 | |
PCT/US1993/009662 WO1994008992A1 (en) | 1992-10-09 | 1993-10-08 | Heterocyclic ether compounds that enhance cognitive function |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE210656T1 true ATE210656T1 (de) | 2001-12-15 |
Family
ID=25501548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93923826T ATE210656T1 (de) | 1992-10-09 | 1993-10-08 | Heterocyclische ether-derivate zur verstärkung der cognitiven funktionen |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0663912B1 (de) |
JP (1) | JP3098035B2 (de) |
KR (1) | KR100311546B1 (de) |
AT (1) | ATE210656T1 (de) |
AU (1) | AU687017B2 (de) |
CA (1) | CA2136075C (de) |
DE (1) | DE69331329T2 (de) |
DK (1) | DK0663912T3 (de) |
ES (1) | ES2169727T3 (de) |
IL (1) | IL107184A (de) |
PT (1) | PT663912E (de) |
WO (1) | WO1994008992A1 (de) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948793A (en) * | 1992-10-09 | 1999-09-07 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release |
US5852041A (en) * | 1993-04-07 | 1998-12-22 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acethylcholine receptors |
US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5998404A (en) * | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
IL118279A (en) * | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
AU7674796A (en) * | 1995-11-13 | 1997-06-05 | Eli Lilly And Company | Method for treating anxiety |
US5794887A (en) | 1995-11-17 | 1998-08-18 | Komerath; Narayanan M. | Stagnation point vortex controller |
US6979695B2 (en) | 1996-04-23 | 2005-12-27 | Targacept, Inc. | Compounds capable of activating cholinergic receptors |
US6437138B1 (en) | 1996-06-06 | 2002-08-20 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
ES2189003T3 (es) * | 1996-12-10 | 2003-07-01 | Abbott Lab | Enantiomeros 3-piridilo y su utilizacion como analgesicos. |
US6133253A (en) * | 1996-12-10 | 2000-10-17 | Abbott Laboratories | 3-Pyridyl enantiomers and their use as analgesics |
CA2287223A1 (en) * | 1997-04-26 | 1998-11-05 | Tomohiro Toyoda | 2-azabicyclo compounds |
US7214686B2 (en) | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
US6624173B1 (en) | 1997-06-30 | 2003-09-23 | Targacept, Inc. | Pharmaceutical compositions for treating and/or preventing CNS disorders |
US6525065B1 (en) | 1997-06-30 | 2003-02-25 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
DK1034174T3 (da) | 1997-11-05 | 2003-09-22 | Neurosearch As | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer |
CA2315117C (en) * | 1997-12-19 | 2011-03-15 | Abbott Laboratories | Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
WO1999051216A2 (en) | 1998-04-02 | 1999-10-14 | R.J. Reynolds Tobacco Company | 3-pyridyloxyalkylamine or aryloxyalkylamine derivatives as cholinergic agonists |
EP1068208B1 (de) * | 1998-04-02 | 2003-05-14 | Targacept, Inc. | Azatricyclo[3.3.1.1]decanderivate und diese enthaltende phrmazeutische zubereitungen |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
US20010031771A1 (en) | 1999-05-24 | 2001-10-18 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
WO2001004091A1 (en) * | 1999-07-09 | 2001-01-18 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
MXPA02002115A (es) * | 1999-09-14 | 2002-10-31 | Abbott Lab | Compuestos de eter 3-pirrolidiniloxi-3'-piridilico, utiles para controlar la transmision sinaptica quimica. . |
US6890935B2 (en) | 1999-11-01 | 2005-05-10 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
US6812314B2 (en) | 2001-10-17 | 2004-11-02 | University Of Florida | Thermally responsive polymer materials and uses thereof |
CA2470567A1 (en) | 2001-12-14 | 2003-06-26 | Targacept, Inc. | Methods and compositions for treatment of central nervous system disorders |
WO2004005293A2 (en) | 2002-07-05 | 2004-01-15 | Targacept, Inc. | N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
WO2004009775A2 (en) | 2002-07-19 | 2004-01-29 | Targacept, Inc. | Methods and compositions relating to chimeric nicotinic receptor subunits |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
US7098331B2 (en) | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
WO2005037832A2 (en) | 2003-10-15 | 2005-04-28 | Targacept, Inc. | Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
CN101948462A (zh) | 2004-09-20 | 2011-01-19 | 塔加西普特公司 | 具有烟碱性胆碱能受体活性的氮杂螺烯和氮杂螺烷化合物 |
US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
UA88792C2 (ru) | 2004-11-10 | 2009-11-25 | Таргасепт, Інк. | Гидроксибензоатные соли метаникотиновых соединений |
KR20080035649A (ko) | 2005-08-22 | 2008-04-23 | 타가셉트 인코포레이티드 | 헤테로아릴로 치환된 디아자트리시클로알칸, 그 제조방법및 용도 |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | (2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型 |
US8017785B2 (en) | 2006-05-09 | 2011-09-13 | Astrazeneca Ab | Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine |
TWI454262B (zh) | 2006-11-02 | 2014-10-01 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
WO2008065145A1 (en) * | 2006-11-29 | 2008-06-05 | Basf Se | Pyridine compounds for combating pests |
US20100028447A1 (en) | 2007-01-22 | 2010-02-04 | Targacept, Inc. | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
TW200845977A (en) | 2007-03-30 | 2008-12-01 | Targacept Inc | Sub-type selective azabicycloalkane derivatives |
JP2010523587A (ja) | 2007-04-02 | 2010-07-15 | パーキンソンズ インスティテュート | 治療処置の副作用の低減のための方法および組成物 |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
US8114891B2 (en) | 2007-10-01 | 2012-02-14 | Comentis, Inc. | 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof |
WO2010045212A2 (en) * | 2008-10-14 | 2010-04-22 | Psychogenics, Incstatuts | Nicotinic acetylcholine receptor ligands and the uses thereof |
US9145396B2 (en) | 2008-12-01 | 2015-09-29 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine |
TW201024283A (en) | 2008-12-01 | 2010-07-01 | Targacept Inc | Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine |
IL266097B (en) | 2008-12-01 | 2022-07-01 | Oyster Point Pharma Inc | Mono-orotate acid addition salt of r(–5–)–e(–2–)pyrrolidine––3ylvinyl)pyrimidine |
WO2010080757A2 (en) | 2009-01-07 | 2010-07-15 | Astrazeneca Ab | Combinations with an alpha-4beta-2 nicotinic agonist |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
KR20120120190A (ko) | 2009-12-07 | 2012-11-01 | 타가셉트 인코포레이티드 | 신경원성 니코틴 아세틸콜린 수용체 리간드인 3,6?디아자비시클로[3.1.1]헵탄 |
SG185497A1 (en) | 2010-05-20 | 2012-12-28 | Astrazeneca Ab | New process for the preparation of aryl substituted olefinic amines |
US8809397B2 (en) | 2010-05-27 | 2014-08-19 | Targacept, Inc. | Nicotinic receptor non-competitive antagonists |
WO2012125518A1 (en) | 2011-03-14 | 2012-09-20 | Targacept, Inc. | Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane |
WO2012129262A1 (en) | 2011-03-23 | 2012-09-27 | Targacept, Inc. | Treatment of attention deficit/hyperactivity disease |
TW201311698A (zh) | 2011-08-22 | 2013-03-16 | Targacept Inc | 作為神經元菸鹼乙醯膽鹼受體配位體之1,4-二氮雜雙環[3.2.2]壬烷 |
WO2013071097A1 (en) | 2011-11-11 | 2013-05-16 | Georgetown University | 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof |
US20170166561A1 (en) | 2014-07-11 | 2017-06-15 | Alpharmagen, Llc | Quinuclidine compounds for modulating alpha7-nicotinic acetylcholine receptor activity |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
US9724340B2 (en) | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
CN105418477B (zh) * | 2015-12-22 | 2018-12-21 | 爱斯特(成都)生物制药股份有限公司 | 降低雷迪帕韦中间体中非对映异构体杂质含量的方法 |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
-
1993
- 1993-10-04 IL IL10718493A patent/IL107184A/xx not_active IP Right Cessation
- 1993-10-08 WO PCT/US1993/009662 patent/WO1994008992A1/en active IP Right Grant
- 1993-10-08 PT PT93923826T patent/PT663912E/pt unknown
- 1993-10-08 EP EP93923826A patent/EP0663912B1/de not_active Expired - Lifetime
- 1993-10-08 KR KR1019940704340A patent/KR100311546B1/ko not_active IP Right Cessation
- 1993-10-08 ES ES93923826T patent/ES2169727T3/es not_active Expired - Lifetime
- 1993-10-08 CA CA002136075A patent/CA2136075C/en not_active Expired - Fee Related
- 1993-10-08 JP JP06510167A patent/JP3098035B2/ja not_active Expired - Fee Related
- 1993-10-08 DK DK93923826T patent/DK0663912T3/da active
- 1993-10-08 AT AT93923826T patent/ATE210656T1/de active
- 1993-10-08 AU AU53557/94A patent/AU687017B2/en not_active Ceased
- 1993-10-08 DE DE69331329T patent/DE69331329T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100311546B1 (ko) | 2005-12-06 |
EP0663912A4 (de) | 1995-02-17 |
JP3098035B2 (ja) | 2000-10-10 |
PT663912E (pt) | 2002-06-28 |
KR950701920A (ko) | 1995-05-17 |
ES2169727T3 (es) | 2002-07-16 |
DK0663912T3 (da) | 2002-04-15 |
EP0663912B1 (de) | 2001-12-12 |
CA2136075A1 (en) | 1994-04-28 |
AU687017B2 (en) | 1998-02-19 |
AU5355794A (en) | 1994-05-09 |
DE69331329D1 (de) | 2002-01-24 |
WO1994008992A1 (en) | 1994-04-28 |
DE69331329T2 (de) | 2002-08-08 |
CA2136075C (en) | 2004-12-14 |
JPH08502481A (ja) | 1996-03-19 |
IL107184A (en) | 1997-08-14 |
IL107184A0 (en) | 1994-01-25 |
EP0663912A1 (de) | 1995-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE210656T1 (de) | Heterocyclische ether-derivate zur verstärkung der cognitiven funktionen | |
FI931888A (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
ATE172463T1 (de) | Pyrrolocarbazol | |
TW429255B (en) | Pyrazine compounds having treatment of central nervous system diseases and disorders | |
ES2195500T3 (es) | Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes. | |
PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
DK0623131T3 (da) | Alkylderivater af trazodon med CNS-aktivitet | |
SE8901060D0 (sv) | New compounds | |
DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
DK52383A (da) | Fremgangsmaade til fremstilling af carbacyklinderivater | |
PT1049670E (pt) | Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc | |
ES2004215A6 (es) | Procedimiento para preparar quinazolinas tetraciclicas | |
ES8705363A1 (es) | Un procedimiento para preparar derivados de tetrahidronaftaleno | |
ATE28628T1 (de) | Phenylethylaminderivate und ihre zwischenprodukte. | |
FI933652A (fi) | Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |